Effect of Reduced-Dose Capecitabine + Cetuximab as Maintenance for RAS Wild-Type Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Clinical Trial
JAMA Netw Open 2020 Jul 01;3(7)e2011036, L Wang, Y Liu, X Yin, W Fang, J Xiong, B Zhao, M Zhang, Y Zou, H Qiu, X YuanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.